Comparison of a job of a medical representative in national versus multinational companies in Pakistan

Sponsored Links

As we know the job description of a medical representative of a pharmaceutical industry is to convey a precise, informative and logical message of his products to his clients. This job description is almost similar in all over the world.

In Pakistan medical representative of a pharmaceutical industry also performs the same duties as mentioned earlier but in a very tough environment. The tough environment means not only the high competition but the clients are also very tough as most of them are sold. These sold clients just take money from the pharmaceutical industries and prescribe their products irrespective of their quality and efficacy. In Pakistan the clients are mostly of this greedy nature. They have no sympathy for their patients. This is really a very dark aspect of this field in Pakistan.

In Pakistan two types of pharmaceutical industries are operating national and multinational. National companies are very large in number and are increasing day by day.

On the other hand multinational companies are in a very minute number. Job description of a medical representative is almost same in a national as well as in a multinational company but some difference is also there. Job in a national company is not secure and is always on threat while in the multinational company the job is secured to some extent. The medical representatives of the multinational companies are properly trained and well equipped with knowledge.Look wise they also look professionals. On the other hand the medical representatives of the national companies have poor knowledge of their products and are not properly trained.

In Pakistan multinational companies work on the ethics and their priority is always the benefits of the patients while the national companies have no ethical background.

National companies just work to earn their profit more and more without considering any benefit of the patients. Similarly medical representatives of the multinational companies work ethically and always for the benefits of the patients. On the other hand medical representatives of the national companies work only for the benefit of their clients and not for the patients. This is the reason due to which the greediness of their clients is increasing day by day. At the end we discuss the basic reason for this difference in the national as well as multinational companies and their representatives.

The basic reason is the unethical registration of the pharmaceutical industries by the ministry of health Pakistan without any solid parameters and standards. Another reason is the unethical promotion of the pharmaceutical products without any proper check. At the end patients suffer from this unethical registration of pharmaceutical industries and unethical promotion of the pharmaceutical products.

This is the reason due to which the resistance of the antibiotics is increasing day by day in the Pakistan as the antibiotics are promoted unethically and without any proper restriction.

Similarly other drugs are also promoted in the same manner as antibiotics are promoted without any proper check.

About the Author

Muhammad Aslam's picture
Author: Muhammad Aslam

Comments

Ph. Bhagavan P S RPh's picture

The observation may be right that the drug clients are sold. But it is neither strange nor a surprise. Doctors in developing countries neither have masters nor are accountable. It may not be difficult to identify a doctor with a particular pharma company to understand a pattern. But, it needs a strong administrative and regulatory measure well supported by political will.

Will it happen?

The fact brought out by Mr Aslamsunara that the National companies are large in number and are increasing day by day is quite interesting. I consider it as a good and healthy trend for the nation and the people in the long run.

As far as job security is concerned except few odd cases here and there job remains secured as long as the employee continues to contribute for the growth and development of the company.

Let us understand that job security and job protection is an obsolete terminology, yet it exists with a rider of performance evaluation and employees utility to the company.

Let us also understand that NCs require manpower and too much of attrition is detrimental to the company itself.

Therefore, it is always good to join broad based companies where there exists what is called HR policy and procedure.

As regards the training quality and professional look etc are concerned the situation was very much the same in 1960s, 70s and 80s in India. Thanks to t he Government of India for having updated Schedule M of the Drugs Act to match with the WHO - GMP and the zeal of the manufacturers to capture the export market and also to have a share in the multinational companies through extending their spare capacity services that resulted in dramatic improvement in the standard and functioning of the Indian pharma companies.

This can be considered as one simple example to show how the system and quality improves with the administrative and regulatory measures supported by political will.

Will it happen?

This comment that MNCs are ethical and NCs are unethical seems overstretching the limits.

I recall that a similar issue had arisen during my service in the Health & FW department in the process of finalizing the bids. Many in the committee were of the opinion as above had hinted indirectly that only 'Reputed' companies should be selected. I succeeded in convincing them not to go by the name or fame of the company but to go by the quality of the company, as there were many instances where small Indian companies having good quality record and so called famous companies having involved in unethical and illegal manipulations.

The comment that MNCs work for patients and NCs work for their clients ( not for the patients) is not totally true. Even today MNCs promote their business through gifts and offers and NCs have to struggle to match with them. The only concern of the common man is that he has to share and bear all such expenditure by paying 2 to 10 times the actual cost of the product + admissible profit. This has been a common phenomenon even in India.

Bottomline:

Drug laws should be updated and should be profession oriented.

Strong administrative and regulatory measures supported by political is a must.

- But will it happen?

Bhagavan P.S. B Pharm

Rtd. Dy Dir.(Pharmacy),Govt of Karnataka, India
Ph. Bhagavan P S RPh's picture

Pardon me, since I didnt find a way out to edit my comment after saving, I am requesting the readers to accept the followi ng correction to my above comment:

............ I succeeded in convincing them not to go by the name or fame of the company but to go by the quality of the company,..........

Please read it as:

I succeeded in convincing them not to go by the name or fame of the company but to go by the quality of the PRODUCT.

Bhagavan P.S. B Pharm

Rtd. Dy Dir.(Pharmacy),Govt of Karnataka, India

You May Also Like..